Abstract Library

#1258 Expressions of CK 19 and CD117 in Hepatic Metastatic Pancreatic Nonfunctional Neuroendocrine Neoplasms

Introduction: The expressions of CK19 and CD117 in pancreatic neoruendocrine neoplasms were considered dismal prognostic factors in some studies, but inconsistent in others.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author:

Authors: Xin B, Lou W, Ji Y, Xie Y, Xu X,

Keywords: CK19, CD117, pNEN, LM, TMA,

#827 Neuroendocrine Tumors of the Pancreas Grade 2 with Ki-67 Index More Than 5% and with Expression Cytokeratin 19 are the Risk Group of Rapid Progression

Introduction: Cytokeratin 19 (CK19) is the marker of pluripotent cells of the epithelium of the pancreatic ducts, which is not detected in differentiated endocrine cells. Our experience shows that many patients with neuroendocrine tumors of the pancreas (pNET) G2 have a rapid progression of the disease a few years after diagnosis, and metastases are found most commonly in the liver.

Conference: 11th Annual ENETSConcerence (2014)

Presenting Author:

Authors: Gurevich L, Korsakova N, Kazantseva I, Egorov A, Britvin T,

Keywords: pancreas, neuroendocrine tumors, risk factors, Ki-67, cytokeratin 19,

#593 The Combination of CK19 and KIT is a Potential Predictor for Clinical Behaviors and Postoperative Outcomes in Resectable Pancreatic Neuroendocrine Tumors

Introduction: We assumed that pNETs is a disease triggered by the re-activation of developmental signaling pathways, once again expressing KIT and CK19.

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author:

Authors: Han X, Zhao J, Ji Y, Xu X, Lou W,

Keywords: pNET, CK19, KIT,

#518 CK19 and KIT Immunostaining is a Useful Adjunct to Ki-67-Based Grading of Pancreatic NET: A Study on Matched Cytological and Histological Samples

Introduction: Pancreatic neuroendocrine tumors (NET) are rare neoplasms. Recent evidence suggests that Ki-67 staining predicts their behavior. Even more recently, a prognostic role has been proposed also for CK19 and KIT. This panel might guide patient management. CK19 and KIT have not yet been evaluated on NET on Fine needle aspiration samples (FNAs).

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: Bellevicine C, Iaccarino A, Faggiano A, Napolitano V, Colao A,

Keywords: FNA, pancreas, NET, Ki-67, Kit, CK19,

#417 CK19 Expression in A?TH-Producing Extrapituitary Neuroendocrine Neoplasms is a Negative Prognostic Factor

Introduction: Defining localization and potential ?CTH-producing extrapituitary neuroendocrine neoplasms (ACTH-epNEN) is important for clinical practice.

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: Gurevich L, Voronkova I, Marova E, Korsakova N, Britvin T,

Keywords: ?C?H-producing neuroendocrine neoplasms, IHC, CK19 expression, prognosis,